Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1961 2
1962 1
1963 2
1964 3
1965 4
1966 4
1967 2
1968 3
1969 1
1970 2
1971 2
1972 3
1973 3
1977 1
1978 2
1979 2
1980 9
1981 9
1982 11
1983 6
1984 4
1985 14
1986 13
1987 8
1988 6
1989 22
1990 4
1991 17
1992 13
1993 8
1994 11
1995 18
1996 23
1997 17
1998 16
1999 18
2000 16
2001 37
2002 37
2003 22
2004 34
2005 39
2006 34
2007 24
2008 24
2009 33
2010 36
2011 34
2012 28
2013 27
2014 17
2015 19
2016 22
2017 27
2018 28
2019 23
2020 28
2021 25
2022 28
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

871 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: furuya h. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Clinical Trial.
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Hosokawa M, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H. Imamura K, et al. Among authors: furuya h. Sci Transl Med. 2017 May 24;9(391):eaaf3962. doi: 10.1126/scitranslmed.aaf3962. Sci Transl Med. 2017. PMID: 28539470 Free article.
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA, Furuya H, Ng ML, Friedemann M, Menschikowski M, Tarasov VV, Chubarev VN, Klochkov SG, Neganova ME, Mangoni AA, Aliev G, Bishayee A. Sukocheva OA, et al. Among authors: furuya h. Pharmacol Ther. 2020 Mar;207:107464. doi: 10.1016/j.pharmthera.2019.107464. Epub 2019 Dec 18. Pharmacol Ther. 2020. PMID: 31863815 Review.
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors.
Nikolos F, Hayashi K, Hoi XP, Alonzo ME, Mo Q, Kasabyan A, Furuya H, Trepel J, Di Vizio D, Guarnerio J, Theodorescu D, Rosser C, Apolo A, Galsky M, Chan KS. Nikolos F, et al. Among authors: furuya h. Nat Commun. 2022 Mar 28;13(1):1487. doi: 10.1038/s41467-022-29026-9. Nat Commun. 2022. PMID: 35347124 Free PMC article.
Randomized Controlled Trial of High-Flow Nasal Cannula in Preterm Infants After Extubation.
Uchiyama A, Okazaki K, Kondo M, Oka S, Motojima Y, Namba F, Nagano N, Yoshikawa K, Kayama K, Kobayashi A, Soeno Y, Numata O, Suenaga H, Imai K, Maruyama H, Fujinaga H, Furuya H, Ito Y; NON-INVASIVE PROCEDURE FOR PREMATURE NEONATES (NIPPN) STUDY GROUP. Uchiyama A, et al. Among authors: furuya h. Pediatrics. 2020 Dec;146(6):e20201101. doi: 10.1542/peds.2020-1101. Pediatrics. 2020. PMID: 33214331 Clinical Trial.
Sphingolipids in cancer.
Furuya H, Shimizu Y, Kawamori T. Furuya H, et al. Cancer Metastasis Rev. 2011 Dec;30(3-4):567-76. doi: 10.1007/s10555-011-9304-1. Cancer Metastasis Rev. 2011. PMID: 22005951 Review.
871 results